These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 35286778)
21. Current biofabrication methods for vascular tissue engineering and an introduction to biological textiles. Kawecki F; L'Heureux N Biofabrication; 2023 Mar; 15(2):. PubMed ID: 36848675 [TBL] [Abstract][Full Text] [Related]
22. Translational tissue-engineered vascular grafts: From bench to bedside. West-Livingston L; Lim JW; Lee SJ Biomaterials; 2023 Nov; 302():122322. PubMed ID: 37713761 [TBL] [Abstract][Full Text] [Related]
23. An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia. Prichard HL; Manson RJ; DiBernardo L; Niklason LE; Lawson JH; Dahl SL J Cardiovasc Transl Res; 2011 Oct; 4(5):674-82. PubMed ID: 21748530 [TBL] [Abstract][Full Text] [Related]
24. Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells. Wang L; Hu J; Sorek CE; Chen EY; Ma PX; Yang B Expert Opin Biol Ther; 2016; 16(3):317-30. PubMed ID: 26560995 [TBL] [Abstract][Full Text] [Related]
26. The Tissue-Engineered Vascular Graft-Past, Present, and Future. Pashneh-Tala S; MacNeil S; Claeyssens F Tissue Eng Part B Rev; 2016 Feb; 22(1):68-100. PubMed ID: 26447530 [TBL] [Abstract][Full Text] [Related]
27. Allogeneic human tissue-engineered blood vessel. Quint C; Arief M; Muto A; Dardik A; Niklason LE J Vasc Surg; 2012 Mar; 55(3):790-8. PubMed ID: 22056286 [TBL] [Abstract][Full Text] [Related]
28. Harnessing the potential of monocytes/macrophages to regenerate tissue-engineered vascular grafts. Das A; Smith RJ; Andreadis ST Cardiovasc Res; 2024 Jul; 120(8):839-854. PubMed ID: 38742656 [TBL] [Abstract][Full Text] [Related]
29. Cardiovascular tissue engineering: state of the art. Vara DS; Salacinski HJ; Kannan RY; Bordenave L; Hamilton G; Seifalian AM Pathol Biol (Paris); 2005 Dec; 53(10):599-612. PubMed ID: 16364812 [TBL] [Abstract][Full Text] [Related]
30. Fast-Degrading Tissue-Engineered Vascular Grafts Lead to Increased Extracellular Matrix Cross-Linking Enzyme Expression. Fukunishi T; Ong CS; He YJ; Inoue T; Zhang H; Steppan J; Matsushita H; Johnson J; Santhanam L; Hibino N Tissue Eng Part A; 2021 Nov; 27(21-22):1368-1375. PubMed ID: 33599167 [TBL] [Abstract][Full Text] [Related]
31. Electrospinning of biomimetic scaffolds for tissue-engineered vascular grafts: threading the path. Woods I; Flanagan TC Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):815-32. PubMed ID: 24903895 [TBL] [Abstract][Full Text] [Related]
32. Tissue engineered vascular grafts: current state of the field. Ong CS; Zhou X; Huang CY; Fukunishi T; Zhang H; Hibino N Expert Rev Med Devices; 2017 May; 14(5):383-392. PubMed ID: 28447487 [TBL] [Abstract][Full Text] [Related]
33. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Hoerstrup SP; Cummings Mrcs I; Lachat M; Schoen FJ; Jenni R; Leschka S; Neuenschwander S; Schmidt D; Mol A; Günter C; Gössi M; Genoni M; Zund G Circulation; 2006 Jul; 114(1 Suppl):I159-66. PubMed ID: 16820566 [TBL] [Abstract][Full Text] [Related]
34. Small-Caliber Tissue-Engineered Vascular Grafts Based on Human-Induced Pluripotent Stem Cells: Progress and Challenges. Ji J; Xu H; Li C; Luo J Tissue Eng Part B Rev; 2023 Aug; 29(4):441-455. PubMed ID: 36884294 [TBL] [Abstract][Full Text] [Related]
35. Dynamic Autologous Reendothelialization of Small-Caliber Arterial Extracellular Matrix: A Preclinical Large Animal Study. Dahan N; Sarig U; Bronshtein T; Baruch L; Karram T; Hoffman A; Machluf M Tissue Eng Part A; 2017 Jan; 23(1-2):69-79. PubMed ID: 27784199 [TBL] [Abstract][Full Text] [Related]
36. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery. Cho SW; Kim IK; Kang JM; Song KW; Kim HS; Park CH; Yoo KJ; Kim BS Tissue Eng Part A; 2009 Apr; 15(4):901-12. PubMed ID: 18783324 [TBL] [Abstract][Full Text] [Related]